Epidemiology of biopsy‐proven giant cell arteritis in <scp>S</scp>outh <scp>A</scp>ustralia
Emma Dunstan(Queen Elizabeth Hospital), Catherine Hill(Royal Adelaide Hospital), P J Roberts-Thomson(Government of South Australia), MJ Ahern(Repatriation General Hospital), Maureen Rischmueller(The University of Adelaide), Thomas J. Dodd(South Australia Pathology), Susan Lester(Queen Elizabeth Hospital), Leslie G. Cleland(Royal Adelaide Hospital), Rachel Black(The University of Sydney)
Cited by 69
Related Papers
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|584
Prevalence, Deaths, and Disability‐Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990–2017
|Arthritis & Rheumatology|2020|395
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
|Arthritis Research & Therapy|2015|116
Risk of mortality in patients with giant cell arteritis: A systematic review and meta-analysis
|Seminars in Arthritis and Rheumatism|2016|83
Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data
|British Journal of Dermatology|2006|52